Skip navigation
Back
Who we are
Together, we are stronger than progressive MS
Members
Executive Committee
Scientific Steering Committee
Industry Forum
Donors, Trusts and Foundations
People Affected by MS Engagement Coordination Team
Fundraising and Communications Work Team
Strategy and Progress Reports
Join us
What we do
Fueling research breakthroughs for people with progressive MS
Understand, prevent and reverse progression
Speed up and improve clinical trials
Improve well-being
Strategy and Progress Reports
Announcements
Menu
Join us
Skip to main content
Announcements
Watch Recent Alliance Global Webcasts on Advancements in Progressive MS Research and Treatment
Read more
International Progressive MS Alliance Seeks People Affected by Progressive MS to Serve on Patient Engagement Team
Read more
Experimental Medicine Trial Development Awards
Read more
Phase 3 Study Continues to Show Tolebrutinib as a Promising Treatment for Non-Relapsing Secondary Progressive MS
Read more
Artificial Intelligence as a Tool to Predict Disease Progression and Treatment Response
Read more
New Study Supported by International Progressive MS Alliance Emphasizes Patient Engagement in Scientific Research from Study Design to Publication
Read more
Alliance-funded Research at ECTRIMS: Focus on Progressive MS
Read more
Alliance Remembers Professor Giancarlo Comi
Read more
Results Announced of “BTK Inhibitor” Tolebrutinib: Delays Time to Disease Progression in Secondary Progressive MS
Read more
Next page
Load more
Who we are
Together, we are stronger than progressive MS
Members
Executive Committee
Scientific Steering Committee
Industry Forum
Donors, Trusts and Foundations
People Affected by MS Engagement Coordination Team
Fundraising and Communications Work Team
Strategy and Progress Reports
Join us
What we do
Fueling research breakthroughs for people with progressive MS
Understand, prevent and reverse progression
Speed up and improve clinical trials
Improve well-being
Strategy and Progress Reports
Announcements
Close modal
